Volume 80, Issue 6, Pages (September 2011)

Slides:

Advertisements

Similar presentations

Medical Technology and Practice Patterns Institute 4733 Bethesda Ave., Suite #510 Bethesda, MD Phone: Fax: Comparison of.

Advertisements

John W. Pickering, PhD, Matthew T. James, MD, PhD, FRCPC, Suetonia C

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Edward D. Siew, Andrew Davenport Kidney International

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

The US Renal Data System “Pie Chart of Death”

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

The risk of hospitalization and modality failure with home dialysis

Volume 64, Issue 3, Pages (September 2003)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Need for better diabetes treatment for improved renal outcome

Volume 85, Issue 1, Pages (January 2014)

Volume 88, Issue 2, Pages (August 2015)

Volume 87, Issue 6, Pages (June 2015)

Homocysteine and risk in end-stage renal disease: a matter of context

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

Volume 80, Issue 9, Pages (November 2011)

Comorbidity and confounding in end-stage renal disease

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 81, Issue 2, Pages (January 2012)

Volume 68, Issue 5, Pages (November 2005)

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Volume 70, Issue 11, Pages (December 2006)

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Patient selection affects end-stage renal disease outcome comparisons

Volume 77, Issue 2, Pages (January 2010)

This Month in AJKD American Journal of Kidney Diseases

Long-term outcomes in nondiabetic chronic kidney disease

Volume 79, Issue 9, Pages (May 2011)

Study of Heart and Renal Protection (SHARP)

U-shaped effect of eGFR and mortality

Volume 76, Issue 10, Pages (November 2009)

The analysis of survival data: the Kaplan–Meier method

Acute myocardial infarction in patients with end-stage renal disease

Volume 83, Issue 4, Pages (April 2013)

Volume 70, Issue 12, Pages (December 2006)

Prescribing and monitoring hemodialysis dose

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Elevated risk of stroke among patients with end-stage renal disease

Volume 83, Issue 2, Pages (February 2013)

Volume 87, Issue 1, Pages (January 2015)

Volume 76, Issue 8, Pages (October 2009)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

Prehypertension: is it relevant for nephrologists?

Volume 70, Issue 3, Pages (August 2006)

Volume 80, Issue 12, Pages (December 2011)

Volume 82, Issue 3, Pages (August 2012)

Carmine Zoccali, Francesca Mallamaci Kidney International

Low triiodothyronine and survival in end-stage renal disease

The Iranian model of living renal transplantation

The Danish Renal Biopsy Register

Michael R. Lattanzio, Matthew R. Weir Kidney International

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Volume 64, Issue 6, Pages (December 2003)

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

Volume 75, Issue 7, Pages (April 2009)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Volume 64, Issue 4, Pages (October 2003)

Volume 82, Issue 9, Pages (November 2012)

Volume 76, Issue 5, Pages (September 2009)

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 80, Issue 6, Pages 663-669 (September 2011) High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes Yi Zhang, Mae Thamer, James S. Kaufman, Dennis J. Cotter, Miguel A. Hernán Kidney International Volume 80, Issue 6, Pages 663-669 (September 2011) DOI: 10.1038/ki.2011.188 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Selection of study population from USRDS data. CE, composite end point; CHF, congestive heart failure; ESRD, end-stage renal disease; MI, myocardial infarction; USRDS, United States Renal Data System. Kidney International 2011 80, 663-669DOI: (10.1038/ki.2011.188) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Adjusted survival curves. (a) Survival probabilities for three selected epoetin dosage regimens: low dosage (15,000U/week), medium dosage (30,000U/week), and high dosage (45,000U/week). (b) Composite outcome defined as death or hospitalization for myocardial infarction, stroke, or congestive heart failure. CI, confidence interval; RD, risk difference; ref., reference. Kidney International 2011 80, 663-669DOI: (10.1038/ki.2011.188) Copyright © 2011 International Society of Nephrology Terms and Conditions